Portuguese BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis (MS) After Conversion to Betaferon by Using Elements of the BetaPlus Program.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2011
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms POR-BetaPlus
- Sponsors Bayer
- 01 Nov 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 01 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2011 Planned End Date changed from 1 May 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.